Reading ARES? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track ARES free→Reading ARES? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track ARES free→QuarterlyIQ Insights · ARES
Price, valuation, and the composite score on the same time axis. Scroll over the price chart to zoom.
Daily closes. Earnings/event dots inline.
A consensus fair price across 3 valuation methods, at three horizons. Current price $135.06. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
No-growth: today's peer multiple on trailing earnings. The headline read.
Embeds projected growth. Leans optimistic by design. Upside context.
Each method's implied share price per horizon. Provisional rows use a projected (historical-CAGR) growth input rather than analyst or management guidance.
| Method | Horizon | Est. price | Multiple | Per-share input | EPS source | Confidence |
|---|---|---|---|---|---|---|
| Peer P/E | 12M | $73.83 | 15.0 | 4.91 | TTM | high |
| PEG | 12M | $143.61 | 29.2 | 4.91 | TTM | high |
| triangulated | 12M | $73.13 | 15.0 | 4.86 | Triangulated | high |
| Peer P/E | 3Y | $160.76 | 15.0 | 10.69 | Analyst | medium |
| PEG | 3Y |
Monthly trailing P/E with quartile reference lines.
A “consensus-then vs. actual-now” overlay is on the way — what our valuation estimate said on a past date versus where the price actually landed.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Long-thesis check; widest uncertainty.
| $312.70 |
| 29.2 |
| 10.69 |
| Analyst |
| medium |
| Peer P/E | 5Y | $270.07 | 15.0 | 17.96 | Analyst | high |
| PEG | 5Y | $525.33 | 29.2 | 17.96 | Analyst | high |